A | 中新网8月26日电 8月26日，国务院台办举行例行新闻发布会。有记者问：近日，台内务主管部门负责人刘世芳称，自去年12月限制小红书APP后，诈骗件数下降80%、诈骗金额下降55%，非常有成效；如今按照程序再给小红书寄挂号信，若仍不理会，很可能再屏蔽一年。 Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。请问对此有何评论？ 国台办发言人张晗表示，你提到的数据是民进党当局自编自导的，目的是捏造借口禁限大陆社交平台，煽动两岸对立对抗。民进党当局粗暴剥夺台湾民众特别是青年的知情权和使用社交平台的自由，粗暴阻挠两岸青年沟通交往，完全不得人心。其倒行逆施挡不住台湾民众通过大陆社交平台进行交流的热情，挡不住两岸民众走亲走近的民意潮流。(中新网“燕新台”工作室) 【编辑:王琴】。
Current article:http://alaf.longdachemakuanshan.pics/list_7b3n8e/lnrdw.html
Published on:07:55:12
